Online digital copies of The OTJ are FREE
The OTJ November 2023

In depth coverage of this month’s surgical and anaesthetic news.
Read online or download the PDF.

Digital Edition Highlights:

Workplace Ostracism is Clearly Associated with Healthcare Workers’ Job Satisfaction, Stress and Perceived Health

London Operating Department Practitioner Advocacy Pilot Project

How to Share Decision-making about Major Surgery for People at High Risk of Complications

Aston University and Simulation Man Launch Overweight Manikin for Medical Student Training

Proportion of People from Black, Asian and Minority Ethnic Communities Registering to Donate on the NHS Organ Donor Register is on the Rise

Trends in Cancer. The World’s First Collection of Brain Metastasis Living Samples Will Help Treat Each Patient with the Most Effective Therapy for them

Mind the (Insurance) Gap. Four out of Five Surgeons Unknowingly Practicing Without Adequate Insurance Cover

Children’s Surgery Magic

Read the pageturn version here

The Operating Theatre Journal November 2023

Latest News

Latest Study Days

Featured Article

New Treatment for Severe Bleeding after Injury Does Not Show Benefit in Clinical Trial
A new technique used to control severe bleeding in injured patients has been found to likely increase the risk of death, according to new research from the University of Aberdeen. The world’s first clinical trial of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) found that patients treated with REBOA were more likely to die …

New Treatment for Severe Bleeding after Injury Does Not Show Benefit in Clinical Trial Read More »

Promotion

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe
Endo International plc (OTC: ENDPQ) announced that its Par Sterile Products business has begun shipping PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection) pre-filled syringe, the first and only FDA-approved neostigmine–glycopyrrolate combination product in the U.S. “This is the latest way we’re addressing operational and clinical challenges in order to support patient care,” said Scott Sims, Senior Vice President …

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Read More »

Sponsored

Sharpsmart's Patented Innovation Transforms Sharps Waste Treatment
When faced with mounting stockpiles of hazardous clinical waste, a global pandemic, and a waste treatment infrastructure that couldn’t cope with the high volumes, it became clear to the healthcare industry that change was crucial. In response, Sharpsmart Ltd, a UK healthcare waste management service provider, took a proactive approach to develop a patented innovation …

Sharpsmart’s Patented Innovation Transforms Sharps Waste Treatment Read More »

Advertisements

DECON UK 2024
Surgical Holdings
Accent Health Recruitment
AneticAid Q3 Opthalmic Stretcher
Bender For Smart, Efficient Operating Theatres
MAT Medical Air Technology
Login to your account